(NASDAQ: PRCT) Procept Biorobotics's forecast annual revenue growth rate of 33.95% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.08%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.48%.
Procept Biorobotics's revenue in 2025 is $224,498,000.On average, 6 Wall Street analysts forecast PRCT's revenue for 2025 to be $17,552,289,916, with the lowest PRCT revenue forecast at $17,520,056,520, and the highest PRCT revenue forecast at $17,607,766,440. On average, 6 Wall Street analysts forecast PRCT's revenue for 2026 to be $23,264,288,818, with the lowest PRCT revenue forecast at $22,470,185,130, and the highest PRCT revenue forecast at $23,903,694,135.
In 2027, PRCT is forecast to generate $29,725,659,350 in revenue, with the lowest revenue forecast at $26,932,427,310 and the highest revenue forecast at $33,036,489,555.